Home » Focus on advanced therapy medicinal products

Focus on advanced therapy medicinal products

by admin
Focus on advanced therapy medicinal products

To medicines for novel therapies (Advanced Therapy Medicinal Products, ATMP) zählen drug with recombinant nucleic acids such as CAR-T cell therapeutics, somatic cell therapies and tissue engineered products. 18 ATMPs currently have EU approval. An excerpt from it was illuminated by Professor Dr. Thomas KlingebielManaging Director of Help for Cancer Patients Kinder Frankfurt am Mainin his lecture »drug for novel therapies: Perspectives, Opportunities, Challenges” at the advanced training congress Pharmacon in Merano.

See also  These shops in Essen's southern district have new tenants

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy